MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
This role will be responsible for owning and supporting Mirum’s Salesforce Life Sciences Cloud (SFLC) platform that powers the Patient CRM and HCP Portal. This Senior Manager role serves as the IT Platform lead with primary accountability for platform stabilization, operational excellence, and scalability following initial implementation and go-live of the Patient Services Hub. Over time, this role will expand to support additional Commercial systems related to customer engagement platforms. The ideal candidate is a highly skilled CRM platform leader with deep experience in regulated life sciences environments, complex CRM implementations, and cross-system integrations.
JOB FUNCTIONS/RESPONSIBILITIES
- Salesforce Platform Ownership & Leadership
- Serve as the IT platform owner for Salesforce Life Sciences Cloud platform supporting Patient CRM and HCP Portal capabilities.
- Assume platform ownership during the final phase of implementation to ramp up, assess solution design, and prepare for steady-state operations.
- Provide strategic leadership for platform stability, scalability, and long-term roadmap post–go-live.
- Own Salesforce account, user, role, profile, and territory management, ensuring appropriate access controls and alignment with business operating models.
- Oversee reporting and dashboard creation, supporting operational visibility for Patient Services and HCP engagement teams.
- Utilize Salesforce Workbench and other approved tools to perform secure data exports, analysis, and issue investigation in support of operational and compliance needs.
- Post–Go-Live Stabilization & Operations
- Lead post-launch stabilization, including production support, incident management, and root cause analysis.
- Own backlog prioritization, defect remediation, and technical debt reduction following initial implementation.
- Establish and mature operational processes, including monitoring, support models, and release management.
- Stakeholder Management & Prioritization
- Partner with Patient Services and business stakeholders to support and enhance the platform
- Ensure platform configurations, data models, security, and workflows align with evolving patient and HCP needs.
- Enable controlled enhancements while minimizing risk to live operations.
- Governance, Compliance & Risk Management
- Own Salesforce platform governance, ensuring alignment with Mirum’s security, privacy, and compliance requirements.
- Implement and enforce change management, access controls, and audit-ready documentation.
- Act as the primary IT escalation point for platform-related risks impacting patient services or HCP engagement.
- Collaboration & Continuous Improvement
- Partner with implementation vendors, integration teams, and enterprise architecture to ensure knowledge transfer and solution continuity.
- Document platform architecture, configurations, and operational procedures to ensure long-term maintainability.
- Stay current on Salesforce Life Sciences Cloud capabilities and recommend improvements that enhance operational efficiency and scalability.
QUALIFICATIONS
- Bachelor’s degree in Computer Science, Information Systems, Engineering, or a related field.
- 6+ years of experience supporting Salesforce platforms in regulated industries, with leadership experience preferred.
- Proven experience owning platforms post-implementation, including stabilization and steady-state operations.
- Strong experience with Salesforce Life Sciences Cloud or complex Salesforce CRM implementations.
- Experience supporting Commercial systems such as Veeva CRM, Master Data Management, Events Management, or similar HCP engagement platforms preferred.
- Demonstrated ability to lead cross-functional teams and manage vendor-delivered solutions.
Knowledge, Skills and Abilities:
- Strong knowledge of core Commercial and Patient Services processes, including territory alignment, HCP/HCO customer master data management, patient enrollment and case management workflows, and compliant HCP engagement.
- Deep expertise in Salesforce architecture, security model, data design, automation, integrations, reporting, and environment management (preferably Salesforce Life Sciences Cloud).
- Proven ability to lead post–go-live stabilization, production support, backlog prioritization, and steady-state platform operations.
- Experience integrating CRM with Commercial ecosystem systems such as MDM, data warehouses, marketing automation, and HCP engagement platforms
- Strong leadership, analytical, and stakeholder management skills with the ability to balance strategic roadmap ownership and hands-on operational accountability.
- Excellent problem-solving and decision-making skills in production environments.
- Strong communication and stakeholder management skills in fast-paced, regulated environments.
The salary range for this position is $190,000 to $205,000 USD. Compensation will be determined based on several factors including, but not limited to; skill set, years of experience, and the employee’s geographic location. Please note that the required compensation details listed in US role postings reflect the base salary only, and do not include bonus, equity, or benefits unless otherwise provided.
#LI-HYBRID
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
Mirum Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Mirum Pharmaceuticals and has not been reviewed or approved by Mirum Pharmaceuticals.
-
Equity Value & Accessibility — Equity grants to new hires and an employee stock purchase plan make ownership more accessible and can boost total rewards when performance is strong. Public disclosures highlight frequent option/RSU inducements.
-
Healthcare Strength — Comprehensive medical, dental, and vision coverage is employer-paid for employees, with added life, disability, and EAP support. This combination reduces financial burden and enhances overall wellbeing.
-
Leave & Time Off Breadth — A broad time-off program includes multiple paid company holidays, a year-end shutdown, accrued vacation, and paid parental leave. This breadth provides additional rest periods beyond standard vacation.
Mirum Pharmaceuticals Insights
Similar Jobs
What We Do
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older. Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome. Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome. Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.
